Compare CTMX & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTMX | NSP |
|---|---|---|
| Founded | 2008 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 977.1M | 819.5M |
| IPO Year | 2015 | 1996 |
| Metric | CTMX | NSP |
|---|---|---|
| Price | $4.90 | $31.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $12.10 | ★ $47.67 |
| AVG Volume (30 Days) | ★ 4.8M | 816.6K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 8.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,201,000.00 | ★ $6,812,000,000.00 |
| Revenue This Year | N/A | $3.45 |
| Revenue Next Year | $7.61 | $6.95 |
| P/E Ratio | $22.58 | ★ N/A |
| Revenue Growth | N/A | ★ 3.51 |
| 52 Week Low | $0.63 | $18.57 |
| 52 Week High | $8.21 | $80.45 |
| Indicator | CTMX | NSP |
|---|---|---|
| Relative Strength Index (RSI) | 54.57 | 67.21 |
| Support Level | $4.02 | $31.00 |
| Resistance Level | $6.20 | $39.86 |
| Average True Range (ATR) | 0.28 | 1.75 |
| MACD | 0.08 | 0.47 |
| Stochastic Oscillator | 79.15 | 96.55 |
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.